98%
921
2 minutes
20
Broad accessibility to cervical cancer screening and high participation rate is essential to reduce cervical cancer incidence. HPV self-sampling is an alternative to clinician collected cervical samples to increase accessibility and screening coverage. To inform on deployment strategies of HPV self-sampling, this large-scale, randomized, pragmatic study compared two invitation modalities; direct-mail and opt-in. The study included screening non-attenders from the Capital Region of Denmark randomly allocated (1:4) to a direct-mail or opt-in invitation for cervical screening by HPV self-sampling. Primary endpoint was screening participation; secondary endpoints were HPV prevalence and histology outcome. Adherence to follow-up and cost were also evaluated. After exclusion of hysterectomized/non-accessible women, 49,393 women were invited: 9639 by direct-mail, and 39,754 by the opt-in offer. A direct-mail invitation for HPV self-sampling yielded a significant higher participation than an opt-in invitation. HPV self-sample participation for direct-mail was 25.2% (n = 2426), opt-in participation was 20.2% (n = 8047), adjusted OR = 1.27, 95% CI 1.20-1.34. Participation increased with age (p < .0001) for both strategies and decreased with screening history of non-attendance (p < .0001). Interaction between invitation strategy and age/screening history was found; more women below 50 years of age participated by direct-mail compared to opt-in (p < .0001) and higher participation by direct-mail group was found in women with a short history of non-attendance (p < .0001). Participation of long-term unscreened women was similar between arms. The relative cost was ≈14 HPV self-sample kits distributed per additional participant by direct-mail over opt-in. HPV prevalence, adherence to follow-up, and detection of high-grade cervical intraepithelial neoplasia was similar between invitation strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826108 | PMC |
http://dx.doi.org/10.1002/ijc.35263 | DOI Listing |
Womens Health Rep (New Rochelle)
August 2025
Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA.
Background: Mailed human papillomavirus (HPV) self-sampling kits improve cervical cancer screening adherence. The HOME trial found information needs and anxiety among HPV-positive patients. We designed a STEP trial to test optimized intervention strategies with bolstered educational materials and a centralized nurse communicating positive results.
View Article and Find Full Text PDFJ Womens Health (Larchmt)
September 2025
Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, Michigan, USA.
Women with physical disabilities (WWPDs) have lower screening rates for cervical cancer than the general population globally. This scoping review aims to define the type of studies and content of studies currently available to promote cervical cancer screening among WWPDs. It seeks to clarify the type of disabilities WWPDs have that lead to the poorest participation in cervical cancer screening and highlight how health care systems can address the disclosed gaps.
View Article and Find Full Text PDFInt J Gynaecol Obstet
September 2025
Division of Preventive Oncology, Karkinos Healthcare, Kerala Operations, Ernakulam, India.
Since the publication of the 2021 FIGO Cancer Report, there has been further progress in the global effort to attain the WHO goal of cervical cancer elimination using a three-pillar approach of vaccination, screening, and treatment. The HPV vaccination is now included in the national program of over 140 countries. Two-dose schedules are being implemented in 80 countries and one-dose schedules in 60 countries.
View Article and Find Full Text PDFCureus
August 2025
Department of Obstetrics and Gynecology, Latifa Women and Children Hospital, Dubai, ARE.
Background: Cervical cancer is one of the leading causes of cancer deaths in women in the United Arab Emirates (UAE), with most deaths attributed to late detection. Most of the cervical cancer cases are linked to infection with sexually transmitted 'high-risk' types of human papillomavirus (HPV). Numerous studies have established the superiority of HPV detection in cervical samples compared to cervical cytology for the primary screening of cervical cancer.
View Article and Find Full Text PDFRev Peru Med Exp Salud Publica
August 2025
Universidad Nacional Mayor de San Marcos, Facultad de Medicina, Lima, Perú.
Background: Motivation for the study. Cervical screening is key to early detection of cancer, but its acceptability limits its implementation. It is essential to understand preferences for self-sampling to facilitate its implementation.
View Article and Find Full Text PDF